These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 681133)

  • 1. Rhodopsin and visual threshold in retinitis pigmentosa.
    Ripps H; Brin KP; Weale RA
    Invest Ophthalmol Vis Sci; 1978 Aug; 17(8):735-45. PubMed ID: 681133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between visual sensitivity and rhodopsin density in retinitis pigmentosa.
    Perlman I; Auerbach E
    Invest Ophthalmol Vis Sci; 1981 Jun; 20(6):758-65. PubMed ID: 7239846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acuity recovery and cone pigment regeneration after a bleach in patients with retinitis pigmentosa and rhodopsin mutations.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2457-61. PubMed ID: 10476820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology.
    Machida S; Kondo M; Jamison JA; Khan NW; Kononen LT; Sugawara T; Bush RA; Sieving PA
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3200-9. PubMed ID: 10967084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual pigment levels in retinitis pigmentosa.
    Kemp CM; Faulkner DJ; Jacobson SG
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 4)():453-7. PubMed ID: 6589863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual acuity and cone spatial density in retinitis pigmentosa.
    Sandberg MA; Berson EL
    Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1511-3. PubMed ID: 6642929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant retinitis pigmentosa caused by the threonine-17-methionine rhodopsin mutation: retinal histopathology and immunocytochemistry.
    Li ZY; Jacobson SG; Milam AH
    Exp Eye Res; 1994 Apr; 58(4):397-408. PubMed ID: 7925677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic effects of the Q64ter rhodopsin mutation in retinitis pigmentosa.
    Milam AH; Li ZY; Cideciyan AV; Jacobson SG
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):753-65. PubMed ID: 8603860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two types of visual dysfunction in autosomal dominant retinitis pigmentosa.
    Kemp CM; Jacobson SG; Faulkner DJ
    Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1235-41. PubMed ID: 3417410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations.
    Berson EL; Rosner B; Weigel-DiFranco C; Dryja TP; Sandberg MA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3027-36. PubMed ID: 12202526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of cone molecular markers in rhodopsin-mutant human retinas with retinitis pigmentosa.
    John SK; Smith JE; Aguirre GD; Milam AH
    Mol Vis; 2000 Nov; 6():204-15. PubMed ID: 11063754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa.
    Li ZY; Wong F; Chang JH; Possin DE; Hao Y; Petters RM; Milam AH
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):808-19. PubMed ID: 9538889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fundus autofluorescence with photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity.
    Robson AG; Egan CA; Luong VA; Bird AC; Holder GE; Fitzke FW
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4119-25. PubMed ID: 15505064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mild phenotype of autosomal dominant retinitis pigmentosa is associated with the rhodopsin mutation Pro-267-Leu.
    Ponjavic V; Abrahamson M; Andréasson S; Ehinger B; Fex G; Polland W
    Ophthalmic Genet; 1997 Jun; 18(2):63-70. PubMed ID: 9228242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa.
    Dryja TP; McGee TL; Reichel E; Hahn LB; Cowley GS; Yandell DW; Sandberg MA; Berson EL
    Nature; 1990 Jan; 343(6256):364-6. PubMed ID: 2137202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of rhodopsin and scotopic retinal sensitivity in sector retinitis pigmentosa.
    Fulton AB; Hansen RM
    Am J Ophthalmol; 1988 Feb; 105(2):132-40. PubMed ID: 3341429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.